- In a rare occurrence, HCMCT Manipal Hospitals, Dwarka treats a 15-year-old boy from Iraq for nasopharyngeal angiofibroma via endonasal endoscopic surgery
Dwarka |3 November 2022: Recently, a 15-year-old boy from Iraq was successfully treated at HCMCT Manipal Hospitals, Dwarka for nasopharyngeal angiofibroma (a rare tumor) through endonasal endoscopic surgery. The patient came to the hospital with a history of nasal obstruction and recurrent nasal bleeding for the past one year. Upon further diagnosis, it was found that there was a large hyper-vascular tumour in his left nasopharynx that had extended to the parapharyngeal space, leading to nasopharyngeal angiofibroma. Looking at his condition, Dr. Ashish and Dr. Shubham immediately decided to perform endonasal endoscopic surgery to save the life of the patient.
Nasopharyngeal angiofibroma is a rare tumour found only in teenage males between the age of 10-20 years and usually causes excessive and profuse nasal bleeding. These tumours pose a treatment challenge as they can bleed profusely during surgery. Although this tumour has a predictable growth pattern and is generally not found in the parapharyngeal space, this particular case posed a big treatment challenge as the patient had undergone prior surgery and radiotherapy in his native country. The patient was planned for tumour embolization and endonasal endoscopic in which the tumour was totally removed after a 6-hour surgery and with blood loss of approximately 700 ml.
Addressing the condition of the patient, Dr. Ashish Vashishth, Consultant-Otorhinolaryngology, Head and Neck and Cranial Base Surgery, Ear, Nose and Throat, HCMCT Manipal Hospitals, Dwarka said, “The patient was previously operated on for this condition in his native country, which posed a major challenge in the treatment. However, our excellent team was able to manage the situation, and the patient showed no complications post-surgery. Although the patient lost almost 700 ml of blood during the surgery, he did not require any blood transfusion and recovered uneventfully in 3 days with no scar or incisions over his face or neck.”
Dr. Shubham Jain, HOD and Consultant – Surgical Oncology, HCMCT, Manipal Hospitals, Dwarka, said, “It was a very complex surgery because of the location of the tumour. Blood loss is very common in this surgery, but the patient was able to take the treatment successfully and he was shifted from the ICU right after one day. Careful planning, multi-departmental collaboration, and robust operative and critical care teamwork can lead to optimal results in such advanced tumours.”
About Manipal Hospitals
As a pioneer in healthcare, Manipal Hospitals is India’s second-largest multi-specialty healthcare provider treating over 4 million patients annually. With its recent acquisition of a 100% stake in Columbia Asia Hospitals in India, the integrated organization today has an enhanced pan-India footprint with 28 hospitals across 14 cities with 7,000+ beds with a talented pool of 4,000+ doctors and 10,000+ employees. Its focus is to develop an affordable, high-quality healthcare framework through its multispecialty and tertiary care delivery spectrum and further extend it to out-of-hospital care. Manipal Hospitals provides comprehensive curative and preventive care for a multitude of patients from around the globe.
Visit EasyShiksha for skill development courses.